S3-E29 – #NASHDay 2022: SurfingNASH Wrap-Up
The SurfingNASH team (Jörn Schattenberg, Louise Campbell, Roger Green) join Global Liver Institute NASH Programs Director Jeff McIntyre for the wrap-up panel of #NASHDay 2022.
June 10, 2022
The SurfingNASH team (Jörn Schattenberg, Louise Campbell, Roger Green) join Global Liver Institute NASH Programs Director Jeff McIntyre for the wrap-up panel of #NASHDay 2022.
The Big Band (Stephen Harrison, Jörn Schattenberg, Louise Campbell, Roger Green) convenes on the eve of #NASHDay 2022 to ask what has changed in the Fatty Liver world in the last twelve months and to recognize the powerful impact of patient advocacy.
Louise Campbell and Rachel Zayas interview Altimmune Chief Medical Officer Scott Harris, and Rachel interviews Antaros Medical Vice President of Global Business Development Caleb Roberts in this mash up of two shorter interviews from our coverage of the 5th Global NASH Congress.
Rachel Zayas interviews Madrigal Pharmaceuticals Founder, Chief Medical Officer and President of R & D Rebecca Taub on the design and some findings from the MAESTRO clinical trials and the importance of patient advocacy.
As the 5th Global NASH Congress comes to an end, Louise Campbell and Rachel Zayas compare notes on the key presentations at the Congress and core NAFLD topics and ideas they are taking away from the event.
Louise Campbell shares highlights from the recent 5th Global NASH Congress, while Jörn Schattenberg and Roger Green share questions and related comments. This conversation focuses on the emerging market for devices that provide portable liver scans and the quality-of-life implications of liver volume changes.
Louise Campbell shares highlights from the recent 5th Global NASH Congress, while Jörn Schattenberg and Roger Green share questions and related comments.
NASH Tsunami covers the 5th Global NASH Congress, with Louise Campbell and Rachel Zayas conducting speaker interviews and Jouise, Rachel, Jörn Schattenberg and Roger Green commenting on conference themes and related areas of interest.
Surfing the NASH Tsunami shares Dr. Marcelo Kugelmas’s portion of the Madrigal Pharmaceuticals presentation at NAFLD, which covers NAFLD patient screening and diagnostics along with NASH patient management. After this, he answers questions from Roger Green, who then interviews Dr. Naim Alkhouri on disease prevalence and strategies for bringing patient to be tested.
Surfing the NASH Tsunami shares Dr. Mazen Noureddin’s portion of the Madrigal Pharmaceuticals presentation at NAFLD, which covers NAFLD pathophysiology and NASH epidemiology. After this, he answers questions from Roger Green.